Analysis of MicroRNAs Expressions in Chondrosarcoma
Overview
Authors
Affiliations
MicroRNAs (miRNAs) are small non-coding RNAs capable of inhibiting gene expression post-transcriptionally and expression profiling can provide therapeutic targets and tools for cancer diagnosis. Chondrosarcoma is a mesenchymal tumor with unknown cause and differentiation status. Here, we profiled miRNA expression of chondrosarcoma, namely clinical samples from human conventional chondrosarcoma tissue, established chondrosarcoma cell lines, and primary non-tumorous adult articular chondrocytes, by miRNA array and quantitative real-time PCR. A wide variety of miRNAs were differently downregulated in chondrosarcoma compared to non-tumorous articular chondrocytes; 27 miRNAs: miR-10b, 23b, 24-1*, 27b, 100, 134, 136, 136*, 138, 181d, 186, 193b, 221*, 222, 335, 337-5p, 376a, 376a*, 376b, 376c, 377, 454, 495, 497, 505, 574-3p, and 660, were significantly downregulated in chondrosarcoma and only 2: miR-96 and 183, were upregulated. We further validated the expression levels of miRNAs by quantitative real-time PCR for miR-181a, let-7a, 100, 222, 136, 376a, and 335 in extended number of chondrosarcoma clinical samples. Among them, all except miR-181a were found to be significantly downregulated in chondrosarcoma derived samples. The findings provide potential diagnostic value and new molecular understanding of chondrosarcoma.
Li F, Xu J, Zhu Y Discov Oncol. 2024; 15(1):175.
PMID: 38762695 PMC: 11102412. DOI: 10.1007/s12672-024-01038-5.
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma.
Skipar P, Dey M, Piatkowski J, Sulejczak D, Rutkowski P, Czarnecka A Int J Mol Sci. 2024; 25(6).
PMID: 38542153 PMC: 10970465. DOI: 10.3390/ijms25063176.
MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells.
Veys C, Boulouard F, Benmoussa A, Jammes M, Brotin E, Redini F Front Oncol. 2023; 13:1220459.
PMID: 37719019 PMC: 10501397. DOI: 10.3389/fonc.2023.1220459.
Epigenetic Abnormalities in Chondrosarcoma.
Bereza M, Dembinski M, Zajac A, Piatkowski J, Dudzisz-Sledz M, Rutkowski P Int J Mol Sci. 2023; 24(5).
PMID: 36901967 PMC: 10003547. DOI: 10.3390/ijms24054539.
Zhang P, Li X, Huang L, Hu F, Niu X, Sun Y Front Oncol. 2022; 12:960269.
PMID: 36016604 PMC: 9396023. DOI: 10.3389/fonc.2022.960269.